<DOC>
	<DOCNO>NCT01224223</DOCNO>
	<brief_summary>Myeloid-derived suppressor cell ( MDSC ) study ability suppress T cell response vivo vitro . As result , MDSC regulate cellular response chronic inflammatory condition cancer , lead induction tolerance , ultimately , tumor escape immune surveillance .</brief_summary>
	<brief_title>Myeloid Suppressors Inflammation</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<criteria>Inclusion 1 . Ages eligible study : 18 60 year 2 . Genders eligible study : male female 3 . Signed date write informed consent obtain prior study blood draw . 4 . Subjects actively treat chronic moderate severe asthma base National Heart Lung Blood Institute guideline ( figure 1 ) . Subjects must carry diagnosis asthma ( make physician ) minimum six month . 5 . Subjects within first seven day acute asthma exacerbation , determine refer physician . 6 . Able give inform consent . 1 . Use systemic corticosteroid within previous two week . 2 . Pregnant and/or lactate female . 3 . Current tobacco use . 4 . Severe psychiatric illness . 5 . Current illicit substance abuse dependence and/or abuse alcohol . 6 . Current use antimicrobial medication . 7 . Primary secondary immunodeficiency . 8 . Any clinically significant uncontrolled medical condition would put patient 's safety risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>asthma</keyword>
</DOC>